EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Annals of the Rheumatic Diseases
Biologic DMARDs and targeted synthetic DMARDs approved for the... | Download Scientific Diagram
Disease-modifying antirheumatic drugs | Download Table
The Korean Journal of Internal Medicine
Conventional disease‐modifying antirheumatic drugs to treat rheumatoid arthritis - Rath - 2011 - Drug Development Research - Wiley Online Library
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
Disease-Modifying Antirheumatic Drug - an overview | ScienceDirect Topics
Traditional disease-modifying antirheumatic drugs (DMARDs) | Download Table
Emerging Treatments for Rheumatoid Arthritis: Update | Consultant360
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan | springermedizin.de
Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis - ScienceDirect
Small Molecule DMARD Therapy and Its Position in RA Treatment | IntechOpen
Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in
LIST OF DMARDS USED TO TREAT RHEUMATOID ARTHRITIS | Download Table
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology
Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms | Annals of the Rheumatic Diseases
Disease-modifying antirheumatic drugs - ScienceDirect
Treatment of Juvenile Idiopathic Arthritis | Pediatric Annals
Schematic of the trial design. DMARD disease modifying antirheumatic... | Download Scientific Diagram
Biomolecules | Free Full-Text | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
